143 related articles for article (PubMed ID: 1830270)
1. Suppression of luteinizing hormone secretion by atrial and brain natriuretic peptides in ovariectomized rats.
Zhang J; Yuen BH; Currie WD; Leung PC
Endocrinology; 1991 Aug; 129(2):801-6. PubMed ID: 1830270
[TBL] [Abstract][Full Text] [Related]
2. C-type natriuretic peptide mediates the hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone secretion.
Samson WK; Huang FL; Fulton RJ
Endocrinology; 1993 Feb; 132(2):504-9. PubMed ID: 8425472
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor inhibits luteinizing hormone secretion in the rat: evidence for a hypothalamic site of action.
Samson WK; Aguila MC; Bianchi R
Endocrinology; 1988 Apr; 122(4):1573-82. PubMed ID: 2964365
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of atrial natriuretic peptide and angiotensin II on luteinizing hormone and prolactin release in female rats.
Steele MK
Neuroendocrinology; 1990 Mar; 51(3):345-50. PubMed ID: 2139185
[TBL] [Abstract][Full Text] [Related]
5. Endogenous opioid regulation of pulsatile luteinizing hormone secretion during sexual maturation in the female sheep.
Ebling FJ; Schwartz ML; Foster DL
Endocrinology; 1989 Jul; 125(1):369-83. PubMed ID: 2737153
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
Kinnunen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1993 May; 132(5):1961-70. PubMed ID: 8477647
[TBL] [Abstract][Full Text] [Related]
7. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
Petraglia F; Sutton S; Vale W; Plotsky P
Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone mediates suppression of pulsatile luteinizing hormone secretion induced by activation of alpha-adrenergic receptors in the paraventricular nucleus in female rats.
Tsukamura H; Nagatani S; Cagampang FR; Kawakami S; Maeda K
Endocrinology; 1994 Mar; 134(3):1460-6. PubMed ID: 8119187
[TBL] [Abstract][Full Text] [Related]
10. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
[TBL] [Abstract][Full Text] [Related]
11. Third-ventricular infusion of neuropeptide Y suppresses luteinizing hormone secretion in ovariectomized rhesus macaques.
Kaynard AH; Pau KY; Hess DL; Spies HG
Endocrinology; 1990 Nov; 127(5):2437-44. PubMed ID: 2226326
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II and atrial natriuretic peptide on LH release are exerted in the preoptic area: possible involvement of gamma-aminobutyric acid (GABA).
Rodriguez Lopez P; Ehlerding A; Leonhardt S; Jarry H; Wuttke W
Exp Clin Endocrinol; 1993; 101(6):350-5. PubMed ID: 8157090
[TBL] [Abstract][Full Text] [Related]
14. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro.
Mäntymaa P; Vuolteenaho O; Marttila M; Ruskoaho H
Endocrinology; 1993 Sep; 133(3):1470-3. PubMed ID: 8365376
[TBL] [Abstract][Full Text] [Related]
15. Role of neuropeptide-Y in episodic luteinizing hormone release in ovariectomized rats: an excitatory component and opioid involvement.
Xu B; Sahu A; Crowley WR; Leranth C; Horvath T; Kalra SP
Endocrinology; 1993 Aug; 133(2):747-54. PubMed ID: 8344213
[TBL] [Abstract][Full Text] [Related]
16. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
Sahu A; Xu B; Kalra SP
Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
[TBL] [Abstract][Full Text] [Related]
17. A decrease in opioid tone amplifies the luteinizing hormone surge in estrogen-treated ovariectomized rats: comparisons with progesterone effects.
Masotto C; Sahu A; Dube MG; Kalra SP
Endocrinology; 1990 Jan; 126(1):18-25. PubMed ID: 2293982
[TBL] [Abstract][Full Text] [Related]
18. Gamma-aminobutyric acid-A and -B receptor antagonists increase luteinizing hormone-releasing hormone neuronal responsiveness to intracerebroventricular norepinephrine in ovariectomized estrogen-treated rats.
Hartman RD; He JR; Barraclough CA
Endocrinology; 1990 Sep; 127(3):1336-45. PubMed ID: 2167216
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal polypeptide effects a central inhibition of pulsatile luteinizing hormone secretion in ovariectomized rats.
Alexander MJ; Clifton DK; Steiner RA
Endocrinology; 1985 Nov; 117(5):2134-9. PubMed ID: 3899617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
